본문 바로가기

반응형

COVID-19 vaccine

반응형
(1)
Moderna's COVID-19 Vaccine, Phase III clinical trials. Early clinical trials by U.S. pharmaceutical company Moderna to develop a new type of coronavirus infection vaccine found that all subjects successfully formed antibodies. There is a high possibility that the Corana 19 vaccine will be released soon. Moderna, a U.S. biotech company, is the most promising company to date in the race to develop a vaccine for the virus that has crippled the global e..